Identification of a Metabolically Stable Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Antimalarial Activity in Mice
- 18 March 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (7), 1864-1872
- https://doi.org/10.1021/jm801343r
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitors with Potent and Selective Activity against the Malaria Parasite Plasmodium falciparumJournal of Medicinal Chemistry, 2008
- Malaria: progress, perils, and prospects for eradicationJCI Insight, 2008
- The Limits and Intensity of Plasmodium falciparum Transmission: Implications for Malaria Control and Elimination WorldwidePLoS Medicine, 2008
- Analysis of Flavin Oxidation and Electron-Transfer Inhibition in Plasmodium falciparum Dihydroorotate DehydrogenaseBiochemistry, 2008
- Detergent-dependent Kinetics of Truncated Plasmodium falciparumDihydroorotate DehydrogenasePublished by Elsevier BV ,2007
- Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparumNature, 2007
- High-throughput Screening for Potent and Selective Inhibitors of Plasmodium falciparum Dihydroorotate DehydrogenasePublished by Elsevier BV ,2005
- Inhibitor binding in a class 2 dihydroorotate dehydrogenase causes variations in the membrane‐associated N‐terminal domainProtein Science, 2004
- Genome sequence of the human malaria parasite Plasmodium falciparumNature, 2002
- Incorporation of Radioactive Precursors into DNA and RNA of Plasmodium knowlesi in vitroThe Journal of Protozoology, 1970